Skip to main content

Advertisement

Table 2 Demography, clinical, and laboratory data comparison between mono-infection and concurrent infections cases during dengue surveillance in Bali

From: Concurrent infections of dengue virus serotypes in Bali, Indonesia

Variable Mono-infection cases (N = 182) Concurrent infections cases (N = 8)
Demography and clinical manifestations
Age, median year (range) 28 (14–75) 42 (25–53)
Male, N (%) 80 (44.0) 7 (87.5)
Female, N (%) 102 (56.0) 1 (12.5)
Fever day, days ± SD 3.3 ± 0.83 2.0 ± 0.93
Headache 139 (76.4) 7 (87.5)
Arthralgia 101 (55.5) 6 (75.0)
Myalgia 122 (67.0) 6 (75.0)
Vomiting 92 (50.5) 2 (25.0
Bleeding 46 (25.3) 2 (25.0)
Plasma leakage 0 (0.0) 0 (0.0)
Shock 0 (0.0) 0 (0.0)
Laboratory examinations data
Nadir WBC (× 10 µg/µL), median (range) 2.1 (0.48–6.4) 2.77 (1.16–4.1)
HCT difference (%), median (range) 13.1 (2.43–68.9) 11.5 (6.1–21.4)
Nadir PLT (× 109/L), median (range) 43 (6–194) 102 (16–122)
DENV NS1 test positivity, N (%) 173 (95.1) 8 (100.0)
Dengue IgM positivity, N (%) 123 (67.6) 7 (87.5)
Dengue IgG positivity, N (%) 142 (78.0) 5 (62.5)
Dengue severity
DF, N (%) 110 (60.4) 6 (75.0)
DHF grade 1, N (%) 42 (23.1) 2 (25.0)
DHF grade 2, N (%) 26 (14.3) 0 (0.0)
DHF grade 3, N (%) 4 (2.2) 0 (0.0)
DHF grade 4, N (%) 0 (0.0) 0 (0.0)
  1. DF, dengue fever; DHF, dengue hemorrhagic fever; WBC, white blood cell; HCT, hematocrit; PLT, platelet